0910-AF25 200504 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative--Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use Other Significant Previously Published in The Unified Agenda Proposed Rule Stage No No 21 CFR 600 21 CFR 601 21 CFR 606 21 CFR 607 21 CFR 610 21 CFR 630 21 CFR 640 21 CFR 660 21 CFR 820 21 CFR 1270 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 360c to 360e 21 USC 360h to 360j 21 USC 360l 21 USC 371 21 USC 372 21 USC 374 21 USC 381 21 USC 383 21 USC 372 42 USC 216 42 USC 243 42 USC 262 42 USC 263 42 USC 263a 42 USC 264 42 USC 271 No NPRM 12/00/2005 No Businesses None No NA Not Collected 0910-AB26 Split from Paula McKeever S. 0910 Food and Drug Administration FDA 301 827-1520 301 443-9718 paula.mckeever@fda.hhs.gov Suite 200N (HFM-17), Office of the Commissioner, Office of Critical Path Programs, 5600 Fishers Lane, Room 14B-45, Rockville MD 20857-0001